Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-01-01 @ 7:58 PM
Study NCT ID:
NCT01386359
Status:
COMPLETED
Last Update Posted:
2022-06-06
First Post:
2011-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-29
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-28
First Submit QC Date:
None
Study First Post Date:
2011-07-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-02
Last Update Post Date:
2022-06-06
Last Update Post Date Type:
ACTUAL